Table 4.
The Prioritization of Telepharmacy Implementation Benefits From the Participants’ Viewpoint.
| Number | Benefits | Mean (SD) |
|---|---|---|
| 1 | The impact of telepharmacy on efficient training of physicians, pharmacists, and patients (medicine usage, drug-drug interactions, and adverse effects) | 3.90 (0.87) |
| 2 | Effect of telemedicine on helping the decision-making and diagnosis of drug interactions | 3.82 (0.81) |
| 3 | The impact of telepharmacy on preventing unnecessary trips to access pharmacy services | 3.77 (0.99) |
| 4 | The effect of telepharmacy on assisting medical services and prevention of diseases | 3.62 (0.97) |
| 5 | The effect of telepharmacy on reducing medical errors | 3.61 (1.18) |
| 6 | The impact of telepharmacy on fair distribution and availability of health services | 3.47 (0.84) |
| 7 | The effect of telepharmacy on improving the quality of health services | 3.47 (0.84) |
| 8 | The effect of telepharmacy on health service cost reduction | 3.25 (1.0) |
| 9 | The effect of telepharmacy on chronic disease control | 3.12 (0.91) |
| 10 | The effect of telepharmacy on increasing satisfaction of pharmacists, physicians and nurses | 3.02 (1.04) |